Projected Impact of HCV Treatment on Near-Term Progression of Advanced Liver Disease in HCV-Infected Patients in a High Prevalence Birth Cohort

被引：0
|
作者：
Rubin, Jaime [1 ]
McGarry, Lisa [1 ]
Panchmatia, Hemangi [1 ]
机构：
[1] Vertex Pharmaceut Inc, Cambridge, MA USA
来源：
AMERICAN JOURNAL OF GASTROENTEROLOGY | 2012年 / 107卷
关键词：
D O I：
10.14309/00000434-201210001-01433
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
1433
引用
收藏
页码：S570 / S570
页数：1
相关论文
共 50 条
  • [31] Does treatment of HCV with DAAs affect renal function? Findings from the German multicenter cohort on direct antiviral agents in HCV- and HIV/HCV-infected patients (GECCO)
    Mauss, S.
    Berger, F.
    Ingiliz, P.
    Christensen, S.
    Hueppe, D.
    Lutz, T.
    Simon, K. G.
    Schewe, K.
    Boesecke, C.
    Busch, H.
    Baumgarten, A.
    ANTIVIRAL THERAPY, 2015, 20 : A66 - A66
  • [32] Long-Term Impact of Direct-Acting Antivirals on Liver Fibrosis and Survival in HCV-Infected Liver Transplant Recipients
    Gambato, Martina
    Manuli, Chiara
    Lynch, Erica N.
    Battistella, Sara
    Germani, Giacomo
    Senzolo, Marco
    Zanetto, Alberto
    Ferrarese, Alberto
    Vitale, Alessandro
    Gringeri, Enrico
    Cillo, Umberto
    Burra, Patrizia
    Russo, Francesco Paolo
    VIRUSES-BASEL, 2023, 15 (08):
  • [33] Control of progression towards liver fibrosis and hepatocellular carcinoma by SOCS3 polymorphisms in chronic HCV-infected patients
    Jadid, Fatima Zahra
    Chihab, Hajar
    Alj, Hanane Salih
    Elfihry, Raouia
    Zaidane, Imane
    Tazi, Sanaa
    Badre, Wafaa
    Marchio, Agnes
    El Filali, Kamal Marhoum
    Tahiri, Mohammed
    Saile, Rachid
    Pineau, Pascal
    Ezzikouri, Sayeh
    Benjelloun, Soumaya
    INFECTION GENETICS AND EVOLUTION, 2018, 66 : 1 - 8
  • [34] RECIPIENTS WITH NASH HAVE HIGHER PREVALENCE AND MORE SEVERE CORONARY ARTERY DISEASE COMPARED TO HCV-INFECTED PATIENTS
    Satapathy, S. K.
    Flowers, A. C.
    Vanatta, J. M.
    Dbouk, N.
    Nair, S. P.
    Eason, J.
    JOURNAL OF HEPATOLOGY, 2014, 60 (01) : S383 - S383
  • [35] HCV core quasispecies change is associated with end stage liver disease in a longitudinal cohort of HCV and HCV/HIV infected patients with inherited bleeding disorders
    Qin, HX
    Shire, NJ
    Rouster, SD
    Eyster, ME
    Goedert, JJ
    Koziel, MJ
    Sherman, KE
    GASTROENTEROLOGY, 2004, 126 (04) : A741 - A741
  • [36] Treatment with direct-acting antiviral agents is associated with improvement of renal function in a cohort of HCV-infected patients with chronic kidney disease
    Masetti, C.
    De Leonardis, F.
    Rossi, P.
    Bosa, A.
    Di Paolo, D.
    Milana, M.
    Santopaolo, F.
    Pecchioli, A.
    Di Nardi, S.
    Francioso, S.
    Lenci, I.
    Baiocchi, L.
    Brega, A.
    Antenucci, F.
    Marianelli, T.
    Angelico, M.
    DIGESTIVE AND LIVER DISEASE, 2017, 49 (01) : E51 - E51
  • [37] Current Trends in Liver Transplantation among HCV-Infected Baby Boomer Generation in the United States: A Case for Birth-Cohort Screening
    Perumpail, Ryan B.
    Liu, Andy
    Jayasekera, Channa R.
    Dieterich, Douglas
    Younossi, Zobair M.
    Wong, Robert J.
    Ahmed, Aijaz
    HEPATOLOGY, 2015, 62 : 309A - 310A
  • [38] Liver stiffness and portal hypertension predict failure to DAA treatment in a real-life cohort of HCV-infected patients treated with recommended regimens
    Masetti, C.
    De Leonardis, F.
    Rossi, P.
    Bosa, A.
    Di Paolo, D.
    Milana, M.
    Santopaolo, F.
    Pecchioli, A.
    Di Nardi, S.
    Francioso, S.
    Lenci, I.
    Baiocchi, L.
    Brega, A.
    Marianelli, T.
    Antenucci, F.
    Angelico, M.
    DIGESTIVE AND LIVER DISEASE, 2017, 49 (01) : E50 - E51
  • [39] AGING OF HEPATITIS C INFECTED PERSONS IN THE UNITED STATES: A MULTIPLE COHORT MODEL OF HCV PREVALENCE AND DISEASE PROGRESSION
    Davis, Gary L.
    Alter, Miriam J.
    El-Serag, Hashem B.
    Poynard, Thierry
    Jennings, Linda W.
    HEPATOLOGY, 2009, 50 (04) : 1050A - 1051A
  • [40] Incidence of liver-related morbidity in a cohort of haemophilia patients: the impact of HAART on HCV progression
    Katsarou, O.
    Ioannidou, P.
    Bakoyannis, G.
    Kouramba, A.
    Touloumi, G.
    Karafoulidou, A.
    HAEMOPHILIA, 2010, 16 : 64 - 64
12345